Tag: cancer

Zantrene at low concentrations kills high FTO producing melanoma cancer cells Sensitivity to Zantrene correlates with FTO levels, where high FTO producing cells show up to 60x greater sensitivity than low FTO producing cells Results are highly supportive of future…

Race Oncology Limited (RAC) is pleased to announce it has produced its first good manufacturing practice (GMP) batch of cancer drug Bisantrene. The first batch will be enough to treat up to sixty patients, with a further four batches scheduled to…